Guardant Health Inc (NASDAQ:GH) currently has a daily average trading volume of 2.19M but it saw 2844058 shares traded in last market. With a market cap of 6.27B USD, the company’s current market price of $50.57 came rising about 2.10 while comparing to the previous closing price of $49.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $52.92 and as low as $20.14.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Mizuho which initiated the stock as “Outperform” in its note to investors issued on April 10, 2025, recommending a price target of $55 for it. Guggenheim issued its recommendations for the stock as it upgraded the price target for the stock is $36.
Over the week, GH’s stock price is moving 3.14% up while it is 25.67% when we observe its performance for the past one month. Year-to-date it is 65.53% up and over the past year, the stock is showing an upside performance of 67.39%.
The company is expected to be releasing its next quarterly report on 2025-Apr-30, for which analysts forecasted an EPS of -0.52 while estimate for next year EPS is -2.0. In next quarter, company is expected to be making quarterly sales of $226.33M as analysts are expecting the sales for current fiscal year at $883.94M and seeing the company making $1.07B in sales next year. Moreover, analysts are in estimates of $211.27M for current-quarter revenue.
Currently, Guardant Health Inc’s total number of outstanding shares is 123.65M. Company’s return on investment (ROI) stands at -40.60% and return on equity (ROE) at -4584.47%. Stock’s beta reads 1.38. Stock has a price to sale or P/S ratio amounts to 8.09. Its return on asset (ROA) is -27.33% on average.
